These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 171162)

  • 1. The effect of blocking dopamine release on synthesis rate of dopamine in the striatum of the rat.
    Van Zwieten-Boot BJ; Noach EL
    Eur J Pharmacol; 1975; 33(2):247-54. PubMed ID: 171162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of a 'cholinergic link' in the apomorphine-induced feedback inhibition of dopamine synthesis in rat striatum.
    Van Zwieten-Boot BJ; Petri-Bot A
    Eur J Pharmacol; 1976 Oct; 39(2):245-50. PubMed ID: 976319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrical stimulation of the nigrostriatal pathway after HA-966 block of triatal dopamine release.
    Van Valkenburg CF; Noach EL
    Eur J Pharmacol; 1978 Mar; 48(2):171-7. PubMed ID: 639847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascorbic acid does not modulate stimulated dopamine release: in vivo voltammetric data in the rat.
    Stamford JA; Kruk ZL; Millar J
    Neurosci Lett; 1985 Oct; 60(3):357-62. PubMed ID: 2999651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The response of non-dopamine neurons in substantia nigra and ventral tegmental area to amphetamine and apomorphine during hypermotility: the striatal influence.
    Olds ME
    Brain Res; 1988 Jun; 452(1-2):237-54. PubMed ID: 3401732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The striatonigral fibres and the feedback control of dopamine metabolism.
    Tulloch IF; Arbuthnott GW; Wright AK; Garcia-Munoz M; Nicolaou NM
    Psychol Med; 1978 Aug; 8(3):471-82. PubMed ID: 30106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3]Pirenzepine binding in rat corpus striatum decreases after hemitransection of the nigro-striatal pathway.
    Pittaluga A; Versace P; Marchi M; Raiteri M
    Fundam Clin Pharmacol; 1987; 1(5):317-25. PubMed ID: 3443424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for dopamine release and metabolism beyond the control of nerve impulses and dopamine receptors in rat substantia nigra.
    Nissbrandt H; Pileblad E; Carlsson A
    J Pharm Pharmacol; 1985 Dec; 37(12):884-9. PubMed ID: 2868096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of dopamine uptake blocking agents on the amphetamine-induced circling behavior in mice with unilateral nigro-striatal lesions.
    Fung YK; Uretsky NJ
    J Pharmacol Exp Ther; 1980 Sep; 214(3):651-6. PubMed ID: 6772760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
    Maggi A; Bruno F; Cattabeni F; Groppetti A; Parenti M; Racagni G
    Brain Res; 1978 Apr; 145(1):180-4. PubMed ID: 205324
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of nigro-striatal dopaminergic neurotransmission in the rat.
    Dray A; Fowler LJ; Oakley NR; Simmonds MA; Tanner T
    Neuropharmacology; 1977; 16(7-8):511-8. PubMed ID: 199852
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential effects of acute and subacute HA-966 treatment on storage and release of striatal dopamine.
    Broxterman HJ; Noach EL; Van Valkenburg CF
    Eur J Pharmacol; 1979 Dec; 60(2-3):153-61. PubMed ID: 527656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release.
    Groppetti A; Parenti M; Cattabeni F; Maggi A; De Angelis L; Monduzzi M; Racagni G
    Adv Biochem Psychopharmacol; 1978; 19():363-71. PubMed ID: 696464
    [No Abstract]   [Full Text] [Related]  

  • 14. Piribedil and apomorphine: pre- and postsynaptic effects on dopamine synthesis and neuronal activity.
    Walters JR; Bunney BS; Roth RH
    Adv Neurol; 1975; 9():273-84. PubMed ID: 167566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotational behavior induced by unilateral electrical stimulations of nigro-striatal dopamine neurons: modification by low doses of apomorphine.
    Barghon R; Costentin JH
    Eur J Pharmacol; 1980 May; 64(1):39-46. PubMed ID: 6969658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catecholamine synthesis in rat brain after axotomy: interaction between apomorphine and haloperidol.
    Kehr W; Carlsson A; Lindqvist M
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(2):111-7. PubMed ID: 193050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in dopamine release from striatal slices of rats after chronic treatment with haloperidol.
    Yamada S; Yokoo H; Harajiri S; Nishi S
    Eur J Pharmacol; 1991 Jan; 192(1):141-5. PubMed ID: 2040357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathway.
    Rice ME; Cragg SJ
    Brain Res Rev; 2008 Aug; 58(2):303-13. PubMed ID: 18433875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apomorphine and haloperidol effects on striatal 3H-dopamine release in anesthetized, awake restrained and freely moving rats.
    Spampinato U; Girault JA; Danguir J; Savaki HE; Glowinski J; Besson MJ
    Brain Res Bull; 1986 Feb; 16(2):161-6. PubMed ID: 3697784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra.
    Robinson TE; Noordhoorn M; Chan EM; Mocsary Z; Camp DM; Whishaw IQ
    Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.